Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001623632-25-001475·FEDERATED HERMES, INC.
Schedule 13D ownership disclosure
Minerva Neurosciences, Inc.
Common Stock · CUSIP: 603380205
Event date: 2025-10-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Federated Hermes, Inc.Reported CIK 0001056288
Shares: 1,351,275.00 · Class: 19.32%
- Voting Shares Irrevocable Trust
Shares: 1,351,275.00 · Class: 19.32%
- Thomas R. Donahue
Shares: 1,351,275.00 · Class: 19.32%
- Ann C. Donahue
Shares: 1,351,275.00 · Class: 19.32%
- J. Christopher Donahue
Shares: 1,351,275.00 · Class: 19.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-25-001475
- Form type
- SCHEDULE 13D
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Oct 28, 2025
- Reporting period
- Oct 21, 2025
- Description
- Schedule 13D beneficial ownership